Gene: PARP3
Official Full Name: poly(ADP-ribose) polymerase family member 3provided by HGNC
Gene Summary: The protein encoded by this gene belongs to the PARP family. These enzymes modify nuclear proteins by poly-ADP-ribosylation, which is required for DNA repair, regulation of apoptosis, and maintenance of genomic stability. This gene encodes the poly(ADP-ribosyl)transferase 3, which is preferentially localized to the daughter centriole throughout the cell cycle. Alternatively spliced transcript variants encoding different isoforms have been identified. [provided by RefSeq, Jul 2008]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO01890 | PARP3 Knockout cell line (HeLa) | Human | PARP3 | 1:3~1:6 | Negative | Online Inquiry |
KO01891 | PARP3 Knockout cell line (HCT 116) | Human | PARP3 | 1:2~1:4 | Negative | Online Inquiry |
KO01892 | PARP3 Knockout cell line (HEK293) | Human | PARP3 | 1:3~1:6 | Negative | Online Inquiry |
KO01893 | PARP3 Knockout cell line (A549) | Human | PARP3 | 1:3~1:4 | Negative | Online Inquiry |
PARP3 Gene Knockout Cell Lines are advanced biological tools designed to facilitate the investigation of the poly(ADP-ribose) polymerase 3 (PARP3) gene's function and its role in various cellular processes. By utilizing CRISPR/Cas9 genome-editing technology, these cell lines have been genetically modified to produce a specific knockout of the PARP3 gene, enabling researchers to explore its contributions to DNA damage repair, cellular stress responses, and programmed cell death (apoptosis).
The key mechanism behind the PARP3 Gene Knockout is the disruption of the PARP3 protein expression, thereby allowing scientists to study the effects of reduced or absent PARP3 activity within the cell. This can provide invaluable insights into the intricate network of repair pathways in eukaryotic organisms, particularly regarding the role of PARP3 in maintaining genomic stability and cellular homeostasis. By studying these knockout lines, researchers can elucidate the complex interactions between PARP3 and other cellular proteins, potentially leading to the discovery of novel therapeutic targets for diseases such as cancer or neurodegenerative disorders.
PARP3 Gene Knockout Cell Lines are particularly significant in both research and clinical settings, offering a reliable model for testing the efficacy of pharmaceutical compounds aimed at modulating PARP3 activity. Compared to alternatives such as transient knockdown approaches, which may yield inconsistent results, these stable cell lines provide reproducible experimental conditions crucial for high-throughput screening and mechanistic studies. Moreover, they eliminate the variability associated with using chemical inhibitors, thereby enhancing the precision of research findings.
For researchers and clinicians looking for robust models to further their understanding of PARP3's biological functions, the PARP3 Gene Knockout Cell Lines present a unique opportunity. Their use could lead to significant advancements in therapeutic strategies, making them an indispensable resource in the field of molecular biology.
Our company specializes in providing high-quality genetic models, underpinned by years of expertise in genetic engineering and cell biology, ensuring that you receive products that not only meet but exceed the highest standards for research excellence.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.